Sign in
4

Changes in Ownership

Serina Therapeutics, Inc. Filed Acc 0001090206-26-000005

Options or other derivatives

  • Chief Executive Officer acquired 380,825 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
LEDGER STEVEN A Chief Executive Officer 2026-05-21 Grant or award · Stock Option (right to buy) +380,825 380,825 D: show line 1 in the form
Loading xslF345X06/wk-form4_1779838635.xml…